Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Before we can even begin to talk about potential therapeutic agents, we have to be on the same page about the condition itself
Conclusion Post-COVID irritable bowel syndrome represents a notable gastrointestinal complication that extends well beyond acute SARS-CoV-2 infection
The National Executive Council (NEC) decision number 204 of 2018, dated August 16, directed that Provincial Services Improvement Programme (PSIP) funds, District Services Improvement Programme (DSIP) funds and Ward level services improvement funds be allocated to five sectors
Novel, potent and selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activities
US$ 20.42
US$ 21.50
US$ 24.37
US$ 20.15
US$ 27.25
